advertisement
11.3.4 Betablocker (10)
Showing records 1 to 10
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker13272 Comparison of the effects of brimonidine 0.2% and timolol 0.5% on retinal nerve fiber layer thickness in ocular hypertensive patients: a prospective, unmasked study
Tsai JC; Chang HW
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 475-482
13457 A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components
Diestelhorst M; Larsson LI; European-Canadian Latanoprost Fixed Combination Study Group
Ophthalmology 2006; 113: 70-76
13546 Comparison of the additive effects of nipradilol and carteolol to latanoprost in open-angle glaucoma
Haneda M; Shirato S; Maruyama K; Ohno Y
Japanese Journal of Ophthalmology 2006; 50: 33-37
13273 Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide) films for long-term intraocular pressure lowering effects
Huang SF; Chen JL; Yeh MK; Chiang CH
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 445-453
13478 Efficacy of latanoprost or fixed-combination latanoprost-timolol in patients switched from a combination of timolol and a nonprostaglandin medication
Magacho L; Reis R; Shetty RK; Santos LC; Avila MP
Ophthalmology 2006; 113: 442-445
13307 Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study
Nieminen T; Uusitalo H; Maenpaa J; Turjanmaa V; Rane A; Lundgren S; Ropo A; Rontu R; Lehtimaki T; Kahonen M
European Journal of Clinical Pharmacology 2005; 61: 811-819
13365 A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma
Parmaksiz S; Yuksel N; Karabas VL; Ozkan B; Demirci G; Caglar Y
European Journal of Ophthalmology 2006; 16: 73-80
13271 Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients
Sakai H; Shinjyo S; Nakamura Y; Ishikawa S; Sawaguchi S
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 483-489
13400 Resting pulse rates in a glaucoma clinic: the effect of topical and systemic β-blocker usage
Tattersall C; Vernon S; Singh R
Eye 2006; 20: 221-225
13277 The effect of D-Timolol and L-Timolol on rat experimental choroidal neovascularization in vivo and endothelial cells in vitro
Xu X-R; Zou Y-H; Chiou GCY
International Journal of Ophthalmology 2005; 5: 831-835
